BridgeBio Pharma
BBIO
$30.90
Share price
3.09%
Change (1 day)
108.19%
Change (1 year)
Categories
BridgeBio Pharma (BBIO) - Total debt
Total debt on the balance sheet as of March 2024 : $1.72 B
According to BridgeBio Pharma 's latest financial reports the company's total debt is $1.72 B. A company’s total debt is the sum of all current and non-current debts.
BridgeBio Pharma - Total debt on balance sheet (from 2018 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $1.73 B | 0.94% |
| 2022-12-31 | $1.72 B | -0.15% |
| 2021-12-31 | $1.72 B | 248.17% |
| 2020-12-31 | $0.49 B | 440.13% |
| 2019-12-31 | $91.79 M | 68.4% |
| 2018-12-31 | $54.5 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $0.32 B | -81.11% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | N/A | N/A | 🇺🇸 USA |